Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

By L. Bartalena, L. Baldeschi, A. Dickinson, A. Eckstein, P. Kendall‐Taylor, C. Marcocci, M. Mourits, P. Perros, K. Boboridis, A. Boschi and 18 more. European Journal of Endocrinology, 2008

761 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/3959fdadad01d6de704a67141013fe49737599f6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Marinò
2. B. Vaidya
3. C. Dayan

Citations in the corpus

• THE 2021 EUROPEAN GROUP ON GRAVES' ORBITOPATHY (EUGOGO) CLINICAL PRACTICE GUIDELINES FOR THE MEDICAL MANAGEMENT OF GRAVES' ORBITOPATHY. (2021, positive): “The EUGOGO classification into mild, moderate-to-severe, and sight-threatening GO (Table 3) has been validated in clinical and research studies (8, 22) and should, therefore, be used.”